drugset
drugset / Trial / NCT01026987

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

NCT01026987 ↗

Phase 1 Completed 29 enrolled Washington University School of Medicine
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Patients who have not had adequate blood count recovery post related or unrelated stem cell transplant will be given a "boost" of T-cell depleted, enriched stem cells to hopefully improve their blood counts.

Timeline

Start
2010-04-29
Primary completion
2014-04
Completion
2016-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AMD3100 Small molecule 320 ug/kg Intravenous
Background G-CSF Unknown 10 ug/kg Subcutaneous

Indications

disease related to hematopoietic stem cell transplant